Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 42, Issue 9 (Sep 2004)

Issues

Homocysteine, vitamin B12 and folate in vascular dementia and in Alzheimer disease

Mariano Malaguarnera / Raffaele Ferri / Rita Bella / Giovanna Alagona / Anna Carnemolla / Giovanni Pennisi
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2004.208

Abstract

The association between elevated plasma levels of homocysteine (Hcy) and nutritional status has been shown in Alzheimer disease (AD) patients and also in vascular dementia (VaD). Moreover, a previous study provided evidence that the relation between a high Hcy level and low vitamin B12 and folate levels in AD patients is due to biochemical damage, rather than a nutritional deficit. The purpose of this study was to investigate the relationship between plasma Hcy levels and vitamins involved in its metabolism in AD and VaD. Twenty-two VaD patients, 22 AD patients and 24 healthy subjects were studied for Hcy, vitamin B12, vitamin B6 and folate. All patients and control subjects were comparable for age, educational level, nutritional and socioeconomic status. None of them showed macrocytic anemia or impaired renal function. Hcy was significantly increased in VaD patients (26.0±6.58 µmol/l) as compared to controls (10.7±3.0 µmol/l) and AD patients (22.3±4.51 µmol/l; p<0.001); however, AD patients also showed increased levels of Hcy. Folates were significantly reduced in both VaD (10.8±2.81 nmol/l) and AD (10.0±2.72 nmol/l; p<0.001) patients, while vitamin B12 showed significantly reduced levels only in AD patients (392.1±65.32 pmol/l; p=0.02). Vitamin B6 was not significantly different in the three groups.

Increased levels of Hcy associated with low vitamin B12 plasma levels were found only in AD patients. This observation led us to consider that vitamin B12 metabolism does not represent the direct consequence of the nutritional status and suggests that neuronal damage results in a functional vitamin B12 deficiency, as emphasized by recent reports. New therapeutic strategies are necessary, considering that available pharmaceutical forms of vitamin B12 are not utilized by neurons in oxidative stress conditions.

Keywords: Alzheimer disease; folate; homocysteine; vascular dementia; vitamin B12

References

  • 1

    Carson NAJ, Neill DW. Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland. Arch Dis Child 1962; 37:505–13.CrossrefGoogle Scholar

  • 2

    Malaguarnera M, Pistone G, Motta M, Vinci E, Oreste G, Avellone G, et al. Elevated plasma total homocysteine in centenarians. Clin Chem Lab Med 2004; 42:307–10.CrossrefGoogle Scholar

  • 3

    Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324:1149–55.Google Scholar

  • 4

    Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998; 55:1449–55.CrossrefGoogle Scholar

  • 5

    McCaddon A, Davies G, Hudson P. Nutritionally independent B12 deficiency and Alzheimer disease. Arch Neurol 2000; 57:607–08.CrossrefGoogle Scholar

  • 6

    Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, Rockwood K, et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl 2000; 59:23–30.Google Scholar

  • 7

    McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984; 34:939–44.CrossrefGoogle Scholar

  • 8

    Dick JP, Guiloff RJ, Stewart A, Blackstock J, Bielawska C, Paul EA, et al. Mini-mental state examination in neurological patients. J Neurol Neurosurg Psychiatry 1984; 47:496–9.CrossrefGoogle Scholar

  • 9

    Guidelines for the management of mild hypertension: memorandum from a World Health Organization – International Society of Hypertension meeting. J Hypertens 1993; 11:905–18.Google Scholar

  • 10

    Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromat 1987; 422:43–52.Google Scholar

  • 11

    Shin Buering Y, Rasshofer R, Endres WA. A new enzymatic method for pyridoxal 5′-phosphate determination. J Inherit Metab Dis 1981; 4:123–4.CrossrefGoogle Scholar

  • 12

    Matas C, Cabrè M, La Ville A, Prats E, Joven J, Turner PR, et al. Limitation of the Friedewald formula for estimating low density lipoprotein cholesterol in alcoholics with liver disease. Clin Chem 1994; 40:404–6.Google Scholar

  • 13

    Friedewald WT, Levy RI, Friedrickson DS. Evaluation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499–502.Google Scholar

  • 14

    Snowdon DA, Tully CL, Smith CD, Riley KP, Markesbery WR. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study. Am J Clin Nutr 2000; 71:993–8.Google Scholar

  • 15

    Wang HX, Wahlin A, Basun H, Fastbom J, Winblad B, Fratiglioni L. Vitamin B(12) and folate in relation to the development of Alzheimer’s disease. Neurology 2001; 56:1188–94.Google Scholar

  • 16

    Lehmann M, Gottfries CG, Regland B. Identification of cognitive impairment in the elderly: homocysteine is an early marker. Dement Geriatr Cogn Disord 1999; 10:12–20.CrossrefGoogle Scholar

  • 17

    Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D’Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med 2002; 346:476–83.Google Scholar

  • 18

    Nilsson K, Gustafson L, Hultberg B. The plasma homocysteine concentration is better than that of serum methylmalonic acid as a marker for sociopsychological performance in a psychogeriatric population. Clin Chem 2000; 46:691–6.Google Scholar

  • 19

    McCaddon A, Davies G, Hudson P, Tandy S, Cattell H. Total serum Hcy in senile dementia of Alzheimer type. Int J Geriatr Psychiatry 1998; 13:235–39.CrossrefGoogle Scholar

  • 20

    Hankey GJ, Eikelboom JW. Hcy and vascular disease. Lancet 1999; 354:407–13.Google Scholar

  • 21

    White AR, Huang X, Jobling MF, Barrow CJ, Beyreuther K, Masters CL, et al. Hcy potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer’s-type neurodegenerative pathways. J Neurochem 2001; 76:1509–20.CrossrefGoogle Scholar

  • 22

    McCaddon A, Regland B, Hudson P, Davies G. Functional vitamin B(12) deficiency and Alzheimer disease. Neurology 2002; 58:1395–9.CrossrefGoogle Scholar

About the article

Corresponding author: Mariano Malaguarnera, Istituto di Medicina Interna e Geriatria-Università di Catania, Ospedale Cannizzaro, Via Messina, 829, 95126 Catania, Italy. Phone: 0039-095-7262008, Fax: 0039-095-7262011, E-mail:


Received: 2003-12-24

Accepted: 2004-06-03

Published Online: 2005-06-01

Published in Print: 2004-09-01


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2004.208.

Export Citation

© Walter de Gruyter. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Clayton L. Ulrey, Liang Liu, Lucy G. Andrews, and Trygve O. Tollefsbol
Human Molecular Genetics, 2005, Volume 14, Number suppl_1, Page R139
[2]
Balázs Szalkai, Vince K. Grolmusz, and Vince I. Grolmusz
Archives of Gerontology and Geriatrics, 2017
[3]
Nasim Mansoori, Manjari Tripathi, Rizwan Alam, Kalpana Luthra, Sumit Sharma, Ramakrishnan Lakshmy, Mani Kalaivani, and Asok K. Mukhopadhyay
American Journal of Alzheimer's Disease & Other Dementiasr, 2014, Volume 29, Number 1, Page 38
[5]
Can Cai, Rong Xiao, Nicholas Van Halm-Lutterodt, Jie Zhen, Xiaochen Huang, Yao Xu, Shuying Chen, and Linhong Yuan
Nutrients, 2016, Volume 8, Number 10, Page 665
[6]
Małgorzata Bednarska-Makaruk, Ałła Graban, Agata Sobczyńska-Malefora, Dominic J. Harrington, Michael Mitchell, Kieran Voong, Letian Dai, Wanda Łojkowska, Anna Bochyńska, Danuta Ryglewicz, Anna Wiśniewska, and Hanna Wehr
Experimental Gerontology, 2016, Volume 81, Page 83
[7]
Yujun Hou, Hyundong Song, Deborah L. Croteau, Mansour Akbari, and Vilhelm A. Bohr
Mechanisms of Ageing and Development, 2017, Volume 161, Page 83
[8]
Ann-Chee Yap, Ummi Mahamad, Shen-Yang Lim, Hae-Jo Kim, and Yeun-Mun Choo
Sensors, 2014, Volume 14, Number 11, Page 21140
[9]
O. Siswanto, K. Smeall, T. Watson, M. Donnelly-Vanderloo, C. O’Connor, N. Foley, and J. Madill
The journal of nutrition, health & aging, 2015, Volume 19, Number 10, Page 1003
[10]
O. Siswanto, K. Smeall, T. Watson, M. Donnelly-Vanderloo, C. O’Connor, N. Foley, and J. Madill
The journal of nutrition, health & aging, 2015
[11]
Abhijeet Jagtap, Sonal Gawande, and Sushil Sharma
Biomarkers and Genomic Medicine, 2015, Volume 7, Number 2, Page 43
[12]
Arun Swaminathan and Gregory A. Jicha
Frontiers in Aging Neuroscience, 2014, Volume 6
[13]
Andrea Guerra, Sara Petrichella, Luca Vollero, David Ponzo, Patrizio Pasqualetti, Sara Määttä, Esa Mervaala, Mervi Könönen, Federica Bressi, Giulio Iannello, Paolo Maria Rossini, and Florinda Ferreri
Clinical Neurophysiology, 2015, Volume 126, Number 5, Page 906
[14]
M. Hasan Mohajeri, Barbara Troesch, and Peter Weber
Nutrition, 2015, Volume 31, Number 2, Page 261
[15]
Giulia Malaguarnera, Caterina Gagliano, Maria Giordano, Salvatore Salomone, Marco Vacante, Claudio Bucolo, Filippo Caraci, Michele Reibaldi, Filippo Drago, Teresio Avitabile, and Massimo Motta
BioMed Research International, 2014, Volume 2014, Page 1
[16]
L. Perez, L. Helm, A. Dean Sherzai, K. Jaceldo-Siegl, and A. Sherzai
The journal of nutrition, health & aging, 2012, Volume 16, Number 4, Page 319
[17]
Eileen Moore, Alastair Mander, David Ames, Ross Carne, Kerrie Sanders, and David Watters
International Psychogeriatrics, 2012, Volume 24, Number 04, Page 541
[18]
Felipe P. Perez, John I. Ilie, Ximing Zhou, Douglas Feinstein, and Donald A. Jurivich
Medical Hypotheses, 2007, Volume 69, Number 1, Page 149
[19]
Emanuela Cazzaniga, Alessandra Bulbarelli, Elena Lonati, Francesca Re, Gloria Galimberti, Elena Gatti, Marina Pitto, Carlo Ferrarese, and Massimo Masserini
Neuroscience Letters, 2008, Volume 436, Number 3, Page 317
[21]
Giovanni Pennisi, Raffaele Ferri, Giovanna Alagona, Manuela Pennisi, Giulia Malaguarnera, Massimo Motta, and Rita Bella
Archives of Gerontology and Geriatrics, 2011, Volume 53, Number 2, Page e111
[22]
Marianna Zana, Zoltán Janka, and János Kálmán
Neurobiology of Aging, 2007, Volume 28, Number 5, Page 648
[23]
Floris Van Dam and Willem A. Van Gool
Archives of Gerontology and Geriatrics, 2009, Volume 48, Number 3, Page 425
[24]
Yeong-Chul Park, Min-Hee Kim, and Jong-Bong Kim
Toxicological Research, 2007, Volume 23, Number 4, Page 311
[25]
Claudio Babiloni, Luisa Benussi, Giuliano Binetti, Paolo Bosco, Gabriella Busonero, Simona Cesaretti, Gloria Dal Forno, Claudio Del Percio, Raffaele Ferri, Giovanni Frisoni, Roberta Ghidoni, Guido Rodriguez, Rosanna Squitti, and Paolo M. Rossini
NeuroImage, 2006, Volume 29, Number 3, Page 948
[26]
Sally I. Sharp, Dag Aarsland, Sarah Day, Hogne Sønnesyn, and Clive Ballard
International Journal of Geriatric Psychiatry, 2011, Volume 26, Number 7, Page 661
[27]
Rima Obeid, Andrew McCaddon, and Wolfgang Herrmann
Clinical Chemical Laboratory Medicine, 2007, Volume 45, Number 12
[28]
Michael Pirchl, Celine Ullrich, and Christian Humpel
European Journal of Neuroscience, 2010, Volume 32, Number 9, Page 1516
[30]
T. Vogel, N. Dali-Youcef, G. Kaltenbach, and E. Andrès
International Journal of Clinical Practice, 2009, Volume 63, Number 7, Page 1061

Comments (0)

Please log in or register to comment.
Log in